Zydus Cadila's COVID-19 vaccine for children above 12 years likely to get DCGI nod this week
ZyCov-D vaccine has been tested on adults as well as children above 12 years of age and the regulatory body experts are satisfied with the results, the officials said.
Jul 12, 2021, 12:40 PM IST
CSIR-Laxai gets DCGI nod for conducting clinical trials of Colchicine on COVID-19 patients
The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients.
Jun 12, 2021, 13:51 PM IST
DCGI gives nod to anti-COVID drug developed by DRDO for emergency use
The Drugs Controller General of India (DCGI) on Saturday (May 8, 2021) approved drug 2-deoxy-D-glucose (2-DG) which is developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in collaboration with Dr Reddy’s Lab.
May 08, 2021, 14:46 PM IST
DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
Aug 03, 2020, 07:55 AM IST
